“…This is also the case in visceral leishmaniasis caused by L. donovani , in mice and humans where IFN-γ-producing Th1 cells protect against severe disease (Kushawaha, Gupta, Sundar, Sahasrabuddhe, & Dube, 2011). In human cutaneous leishmaniasis IFN-γ production by CD8+ T cells seems to contribute to disease resolution (Mary, Auriault, Faugère, & Dessein, 1999; Nateghi Rostami et al, 2010). However, as demonstrated by Leishmania infection models using CD4 or CD8 deficient mice, while CD4 T cells are required for resolution of disease (Chakkalath et al, 1995), the role of CD8 T cells in immunity to cutaneous or visceral leishmaniasis seems to depend on the model used (Belkaid, Von Stebut, et al, 2002; Erb, Blank, Ritter, Bluethmann, & Moll, 1996; Gomes-Pereira, Rodrigues, Rolão, Almeida, & Santos-Gomes, 2004; Huber, Timms, Mak, Röllinghoff, & Lohoff, 1998; Tsagozis, Karagouni, & Dotsika, 2005).…”